The Economist on The Drug Industry

Ranbaxy, a big Indian generics firm, gobbled up six competitors last year and is now talking with private-equity firms about a bid for the generics arm of Germany's Merck. Ranbaxy's boss, Malvinder Singh, scoffs that Big Pharma "is struggling to come up with true innovation".

He'd better hope we do, though. Where else is Ranbaxy going to get those generic drugs to sell, do you think? From elves?

Ha.